These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 22349684)
1. A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset Alzheimer's disease. Serot JM; Zmudka J; Jouanny P J Alzheimers Dis; 2012; 30(1):17-26. PubMed ID: 22349684 [TBL] [Abstract][Full Text] [Related]
2. Human choroid plexus growth factors: What are the implications for CSF dynamics in Alzheimer's disease? Stopa EG; Berzin TM; Kim S; Song P; Kuo-LeBlanc V; Rodriguez-Wolf M; Baird A; Johanson CE Exp Neurol; 2001 Jan; 167(1):40-7. PubMed ID: 11161591 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid from Alzheimer's disease patients promotes amyloid beta-protein oligomerization. Ikeda T; Ono K; Elashoff D; Condron MM; Noguchi-Shinohara M; Yoshita M; Teplow DB; Yamada M J Alzheimers Dis; 2010; 21(1):81-6. PubMed ID: 20413863 [TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758 [TBL] [Abstract][Full Text] [Related]
5. Oligomerization partially explains the lowering of Abeta42 in Alzheimer's disease cerebrospinal fluid. Englund H; Degerman Gunnarsson M; Brundin RM; Hedlund M; Kilander L; Lannfelt L; Pettersson FE Neurodegener Dis; 2009; 6(4):139-47. PubMed ID: 19521063 [TBL] [Abstract][Full Text] [Related]
6. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Fagan AM; Mintun MA; Mach RH; Lee SY; Dence CS; Shah AR; LaRossa GN; Spinner ML; Klunk WE; Mathis CA; DeKosky ST; Morris JC; Holtzman DM Ann Neurol; 2006 Mar; 59(3):512-9. PubMed ID: 16372280 [TBL] [Abstract][Full Text] [Related]
7. Genes involved in cerebrospinal fluid production as candidate genes for late-onset Alzheimer's disease: a hypothesis. Wostyn P; van Dam D; Audenaert K; de Deyn PP J Neurogenet; 2011 Dec; 25(4):195-200. PubMed ID: 22023247 [TBL] [Abstract][Full Text] [Related]
9. Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls. Sundelöf J; Sundström J; Hansson O; Eriksdotter-Jönhagen M; Giedraitis V; Larsson A; Degerman-Gunnarsson M; Ingelsson M; Minthon L; Blennow K; Kilander L; Basun H; Lannfelt L J Alzheimers Dis; 2010; 21(2):471-8. PubMed ID: 20555147 [TBL] [Abstract][Full Text] [Related]
10. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand. Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431 [TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid profile of amyloid β42 (Aβ42), hTau and ubiquitin in North Indian Alzheimer's disease patients. Kandimalla RJ; S P; Bk B; Wani WY; Sharma DR; Grover VK; Bhardwaj N; Jain K; Gill KD Neurosci Lett; 2011 Jan; 487(2):134-8. PubMed ID: 20599474 [TBL] [Abstract][Full Text] [Related]
12. Amyloid-β peptide(1-40) elimination from cerebrospinal fluid involves low-density lipoprotein receptor-related protein 1 at the blood-cerebrospinal fluid barrier. Fujiyoshi M; Tachikawa M; Ohtsuki S; Ito S; Uchida Y; Akanuma S; Kamiie J; Hashimoto T; Hosoya K; Iwatsubo T; Terasaki T J Neurochem; 2011 Aug; 118(3):407-15. PubMed ID: 21585370 [TBL] [Abstract][Full Text] [Related]
13. Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor. Banks WA; Kumar VB; Farr SA; Nakaoke R; Robinson SM; Morley JE J Alzheimers Dis; 2011; 23(4):599-605. PubMed ID: 21098986 [TBL] [Abstract][Full Text] [Related]
14. Estrogen receptors alpha and beta in choroid plexus epithelial cells in Alzheimer's disease. Hong-Goka BC; Chang FL Neurosci Lett; 2004 Apr; 360(3):113-6. PubMed ID: 15082146 [TBL] [Abstract][Full Text] [Related]
15. Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment. Hansson O; Zetterberg H; Buchhave P; Andreasson U; Londos E; Minthon L; Blennow K Dement Geriatr Cogn Disord; 2007; 23(5):316-20. PubMed ID: 17374949 [TBL] [Abstract][Full Text] [Related]
16. Increased CSF-BACE1 activity associated with decreased hippocampus volume in Alzheimer's disease. Ewers M; Cheng X; Zhong Z; Nural HF; Walsh C; Meindl T; Teipel SJ; Buerger K; He P; Shen Y; Hampel H J Alzheimers Dis; 2011; 25(2):373-81. PubMed ID: 21460439 [TBL] [Abstract][Full Text] [Related]
17. Dissociation of β-amyloid from lipoprotein in cerebrospinal fluid from Alzheimer's disease accelerates β-amyloid-42 assembly. Takamura A; Kawarabayashi T; Yokoseki T; Shibata M; Morishima-Kawashima M; Saito Y; Murayama S; Ihara Y; Abe K; Shoji M; Michikawa M; Matsubara E J Neurosci Res; 2011 Jun; 89(6):815-21. PubMed ID: 21394760 [TBL] [Abstract][Full Text] [Related]
18. Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: implications for the pathogenesis of Alzheimer's disease. Hasegawa T; Ukai W; Jo DG; Xu X; Mattson MP; Nakagawa M; Araki W; Saito T; Yamada T J Neurosci Res; 2005 Jun; 80(6):869-76. PubMed ID: 15898106 [TBL] [Abstract][Full Text] [Related]
19. [The role of CSF markers in the early diagnosis of Alzheimer's disease]. Vos SJ; Visser PJ; Verhey FR Tijdschr Psychiatr; 2011; 53(9):647-53. PubMed ID: 21898322 [TBL] [Abstract][Full Text] [Related]